While we propose that PPE51 exerts its functions mainly as a TLR2 antagonist, it could be proposed that a bacterial advantage exists if Mtb produces both agonistic and antagonistic TLR ligands, perhaps at different stages of infection or in different host microenvironments. The gene discussed is TLR2; the disease is infection.